104.45CAD+4.86%Mkt Cap: 736.87M $P/E: —22d ago
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which ar…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap736.87M $
Enterprise Value561.83M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.91M $
Revenue/Share—
Last Price104.45 CAD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees26
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.40
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.51
EPS (TTM)-2.84
EPS (Forward)-8.16
52W Range
44.6948% of range170.00
52W High170.00 CAD
52W Low44.69 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-14.91%
ROA-14.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.33M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1.86%
Net Debt-224.13M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio121.97
Quick Ratio121.44
Book Value/Sh31.20 CAD
Cash/Share31.21 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJul 14, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)139.33 CAD
Upside (mean)+33.4%
Target Range126.00 CAD – 147.00 CAD
CAD126.00+33.4% to meanCAD147.00
# Analysts3
Ownership
Shares Out.9.81M
Float6.21M
Insiders11.94%
Institutions94.85%
Short Interest
Short Ratio5.1d
Short % Float0.07%
Short % Out.0.05%
Shares Short5.00K
Short (prev mo.)3.02K
Technical
SMA 50100.64 (+3.8%)
SMA 200106.72 (-2.1%)
Beta0.09
S&P 52W Chg18.16%
Avg Vol (30d)1.02K
Avg Vol (10d)465
Technical Indicators
RSI (14)53.4
MACD0.8461
MACD Signal1.1790
MACD Hist.-0.3329
BB Upper113.22 CAD
BB Middle102.74 CAD
BB Lower92.26 CAD
BB Width20.40%
ATR (14)4.588 CAD
Vol Ratio (20d)1.08x